insights_auto
Why is HNSA down 2,78%?
Dive Deeperchevron_right
HNSA:STO
Hansa Biopharma AB
48,18 SEK
arrow_downward
-2,78%(-1,38) 1D
17 նոյ, 17:29:39 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HNSA...
Open
49,26 SEK
High
49,76 SEK
Low
47,50 SEK
Mkt. cap
4,90 մլրդ
Avg. vol.
712,68 հզր
Volume
1,15 մլն
52-wk high
51,65 SEK
52-wk low
23,52 SEK
EPS
-7,91 SEK
Shares outstanding
101,76 մլն
No. of employees
111
Open
49,26 SEK
High
49,76 SEK
Low
47,50 SEK
Mkt. cap
4,90 մլրդ
Avg. vol.
712,68 հզր
Volume
1,15 մլն
52-wk high
51,65 SEK
52-wk low
23,52 SEK
EPS
-7,91 SEK
Shares outstanding
101,76 մլն
No. of employees
111
News stories
From web sources and news partners
Investing.com UK
·
8 ժամ առաջ
Hansa Biopharma at Jefferies: transplant drug nears key U.S. test By Investing.com
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees111
Founded2007
Headquarters-
SectorHealth Care
Industry-
Websitehansabiopharma.com